Cargando…

Clinical, Economic, and Quality of Life Impact of Atrial Fibrillation

BACKGROUND: Atrial fibrillation (AF) is a common, age-related arrhythmia that disproportionately affects men, adversely affects quality of life, and causes considerable morbidity and mortality. OBJECTIVES: To describe trends in the prevalence and incidence of AF in theUnited States; discuss the etio...

Descripción completa

Detalles Bibliográficos
Autor principal: Sanoski, Cynthia A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academy of Managed Care Pharmacy 2009
Materias:
Cea
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10442900/
https://www.ncbi.nlm.nih.gov/pubmed/19678721
http://dx.doi.org/10.18553/jmcp.2009.15.s6-b.4
_version_ 1785093701632000000
author Sanoski, Cynthia A.
author_facet Sanoski, Cynthia A.
author_sort Sanoski, Cynthia A.
collection PubMed
description BACKGROUND: Atrial fibrillation (AF) is a common, age-related arrhythmia that disproportionately affects men, adversely affects quality of life, and causes considerable morbidity and mortality. OBJECTIVES: To describe trends in the prevalence and incidence of AF in theUnited States; discuss the etiologies and complications of AF; characterize the economic burden of AF; and predict an individual’s risk for developing AF and AF-related stroke. SUMMARY: The prevalence and incidence of AF in the United States are expected to increase in the coming decades because of the aging of the population; improved survival rates associated with coronary heart disease,heart failure, and hypertension; and increased rate of performance of surgical procedures. The economic burden of AF is substantial because of high rates of hospitalization and other health resource utilization. Hypertension, coronary heart disease, and systolic heart failure are the most important risk factors for AF. Ischemic stroke is the most devastating complication of AF. Risk factors for stroke in patients with AF include recent congestive heart failure,hypertension, advanced age, diabetes mellitus, and a history of stroke or transientischemic attack. Risk scoring systems have been developed to predict an individual’s risk for developing AF and the risk for stroke in a patient withAF. The estimated lifetime risk for AF in men and women aged 40 years of age or older is 1 in 4, which is higher than the risk for other diseases that are a common cause for concern among elderly patients. CONCLUSIONS: The clinical and economic burden of AF in the United States islarge and will continue to increase in the future. The use of scoring systems to predict the risk of AF and AF-related stroke affords clinicians the opportunity to intervene to minimize these risks and improve patient outcomes. 
format Online
Article
Text
id pubmed-10442900
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher Academy of Managed Care Pharmacy
record_format MEDLINE/PubMed
spelling pubmed-104429002023-08-23 Clinical, Economic, and Quality of Life Impact of Atrial Fibrillation Sanoski, Cynthia A. J Manag Care Pharm Cea BACKGROUND: Atrial fibrillation (AF) is a common, age-related arrhythmia that disproportionately affects men, adversely affects quality of life, and causes considerable morbidity and mortality. OBJECTIVES: To describe trends in the prevalence and incidence of AF in theUnited States; discuss the etiologies and complications of AF; characterize the economic burden of AF; and predict an individual’s risk for developing AF and AF-related stroke. SUMMARY: The prevalence and incidence of AF in the United States are expected to increase in the coming decades because of the aging of the population; improved survival rates associated with coronary heart disease,heart failure, and hypertension; and increased rate of performance of surgical procedures. The economic burden of AF is substantial because of high rates of hospitalization and other health resource utilization. Hypertension, coronary heart disease, and systolic heart failure are the most important risk factors for AF. Ischemic stroke is the most devastating complication of AF. Risk factors for stroke in patients with AF include recent congestive heart failure,hypertension, advanced age, diabetes mellitus, and a history of stroke or transientischemic attack. Risk scoring systems have been developed to predict an individual’s risk for developing AF and the risk for stroke in a patient withAF. The estimated lifetime risk for AF in men and women aged 40 years of age or older is 1 in 4, which is higher than the risk for other diseases that are a common cause for concern among elderly patients. CONCLUSIONS: The clinical and economic burden of AF in the United States islarge and will continue to increase in the future. The use of scoring systems to predict the risk of AF and AF-related stroke affords clinicians the opportunity to intervene to minimize these risks and improve patient outcomes.  Academy of Managed Care Pharmacy 2009-08 /pmc/articles/PMC10442900/ /pubmed/19678721 http://dx.doi.org/10.18553/jmcp.2009.15.s6-b.4 Text en Copyright © 2009, Academy of Managed Care Pharmacy. All rights reserved. https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits unrestricted use and redistribution provided that the original author and source are credited.
spellingShingle Cea
Sanoski, Cynthia A.
Clinical, Economic, and Quality of Life Impact of Atrial Fibrillation
title Clinical, Economic, and Quality of Life Impact of Atrial Fibrillation
title_full Clinical, Economic, and Quality of Life Impact of Atrial Fibrillation
title_fullStr Clinical, Economic, and Quality of Life Impact of Atrial Fibrillation
title_full_unstemmed Clinical, Economic, and Quality of Life Impact of Atrial Fibrillation
title_short Clinical, Economic, and Quality of Life Impact of Atrial Fibrillation
title_sort clinical, economic, and quality of life impact of atrial fibrillation
topic Cea
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10442900/
https://www.ncbi.nlm.nih.gov/pubmed/19678721
http://dx.doi.org/10.18553/jmcp.2009.15.s6-b.4
work_keys_str_mv AT sanoskicynthiaa clinicaleconomicandqualityoflifeimpactofatrialfibrillation